AACR logo

More articles from Research Article

[89Zr]ZrDFO-CR011 positron emission tomography correlates with response to glycoprotein non-metastatic melanoma B-targeted therapy in triple negative breast cancer
Supum Lee, Alessandra Cavaliere, Jean-Dominique Gallezot, Tibor Keler, Sharon K Michelhaugh, Erika Belitzky, Michael Liu, Timothy Mulnix, Stephen E Maher, Alfred L.M. Bothwell, Fangyong Li, Manali Phadke, Sandeep Mittal, Bernadette Marquez-Nostra

Molecular Cancer Therapeutics Jan 2022, molcanther.0590.2021; DOI: 10.1158/1535-7163.MCT-21-0590
Targeting protein arginine methyltransferase 5 (PRMT5) suppresses radiation-induced neuroendocrine differentiation and sensitizes prostate cancer cells to radiation
Jake L. Owens, Elena Beketova, Sheng Liu, Qi Shen, Jogendra Singh Pawar, Andrew M Asberry, Jie Yang, Xuehong Deng, Bennett D. Elzey, Timothy L. Ratliff, Liang Cheng, C. Richard Choo, Deborah E. Citrin, Thomas J Polascik, Bangchen Wang, Jiaoti Huang, Chenglong Li, Jun Wan, Chang-Deng Hu

Molecular Cancer Therapeutics Jan 2022, molcanther.MCT-21-0103-A.2021; DOI: 10.1158/1535-7163.MCT-21-0103
Novel group C oncolytic adenoviruses carrying a microRNA inhibitor demonstrate enhanced oncolytic activity in vitro and in vivo
Johannes Doerner, Erwan Sallard, Wenli Zhang, Manish Solanki, Jing Liu, Eric Ehrke-Schulz, Hubert Zirngibl, André Lieber, Anja Ehrhardt

Molecular Cancer Therapeutics Jan 2022, molcanther.MCT-21-0240-A.2021; DOI: 10.1158/1535-7163.MCT-21-0240
Local treatment of a pediatric osteosarcoma model with a 4-1BBL armed oncolytic adenovirus results in an antitumor effect and leads to immune memory
Naiara Martínez-Vélez, Virginia Laspidea, Marta Zalacain, Sara Labiano, Marc Garcia-Moure, Montserrat Puigdelloses, Lucia Marrodan, Marisol Gonzalez-Huarriz, Guillermo Herrador, Daniel de la Nava, Iker Ausejo-Mauleon, Juan Fueyo, Candelaria Gomez-Manzano, Ana Patiño-García, Marta M Alonso

Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-21-0565-A.2021; DOI: 10.1158/1535-7163.MCT-21-0565
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models
Peter Georgiev, Eric S Muise, Douglas E. Linn, Marlene C. Hinton, Yun Wang, Mingmei Cai, Louise Cadzow, Douglas C. Wilson, Selvakumar Sukumar, Michael Caniga, Lan Chen, Hui Xiao, Jennifer H Yearley, Venkataraman Sriram, Michael Nebozhyn, Manjiri Sathe, Wendy M Blumenschein, Kimberly S. Kerr, Heather A. Hirsch, Sarah Javaid, Aleksandra K. Olow, Lily Y Moy, Derek Y Chiang, Andrey Loboda, Razvan Cristescu, Svetlana Sadekova, Brian J Long, Terrill K. McClanahan, Elaine M Pinheiro

Molecular Cancer Therapeutics Jan 2021, molcanther.0561.2021; DOI: 10.1158/1535-7163.MCT-21-0561
Targeting IKKε in androgen-independent prostate cancer causes phenotypic senescence and genomic instability
Sophie Gilbert, Benjamin Péant, Nicolas Malaquin, Véronique Tu, Hubert Fleury, Kim Leclerc-Desaulniers, Francis Rodier, Anne-Marie Mes-Masson, Fred Saad

Molecular Cancer Therapeutics Jan 2021, molcanther.0519.2021; DOI: 10.1158/1535-7163.MCT-21-0519
Comparative study on the efficacy and exposure of molecular target agents in non-small cell lung cancer PDX models with driver genetic alterations
Hitomi Jo, Shigehiro Yagishita, Yoshiharu Hayashi, Shoraku Ryu, Mikiko Suzuki, Shinji Kohsaka, Toshihide Ueno, Yuji Matsumoto, Hidehito Horinouchi, Yuichiro Ohe, Shun-ichi Watanabe, Noriko Motoi, Yasushi Yatabe, Hiroyuki Mano, Kazuhisa Takahashi, Akinobu Hamada

Molecular Cancer Therapeutics Jan 2021, molcanther.0371.2021; DOI: 10.1158/1535-7163.MCT-21-0371
Cellular-Resolution Imaging of Bystander Payload Tissue Penetration from Antibody-Drug Conjugates
Eshita Khera, Shujun Dong, Haolong Huang, Laureen de Bever, Floris L. van Delft, Greg M Thurber

Molecular Cancer Therapeutics Jan 2021, molcanther.0580.2021; DOI: 10.1158/1535-7163.MCT-21-0580
Runx2 deficiency in osteoblasts promotes myeloma resistance to bortezomib by increasing TSP-1-dependent TGF-β1 activation and suppressing immunity in bone marrow
Chao Zhang, Xiaoxuan Xu, Timothy N. Trotter, Pramod S. Gowda, Yun Lu, Mark J Suto, Amjad Javed, Joanne E. Murphy-Ullrich, Juan Li, Yang Yang

Molecular Cancer Therapeutics Jan 2021, molcanther.0310.2021; DOI: 10.1158/1535-7163.MCT-21-0310
Resistance profile and structural modeling of next-generation ROS1 tyrosine kinase inhibitors
Clare Keddy, Pushkar Shinde, Kristen Jones, Stefanie Kaech, Romel Somwar, Ujwal Shinde, Monika A Davare

Molecular Cancer Therapeutics Jan 2021, molcanther.MCT-21-0395-A.2021; DOI: 10.1158/1535-7163.MCT-21-0395

Main menu

User menu

Search

More articles from Research Article

Pages

Articles

Info for

About MCT